Tauri Group has secured two new task orders to provide support services for the US Department of Defense’s (DoD) Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD).
The orders have been awarded under the JPEO-CBD Omnibus Program Engineering and Technical Support (OPETS) medical domain.
Under the task order contracts, the company is responsible for providing support services for the development and use of chemical and biological defence materials.
Awarded as a re-compete win, the current task order enables bioengineers and scientists to support the JPEO-CBD joint project manager (JPM) for Medical Countermeasures Systems, JPM for Protection and Guardian JPM.
Under the second task order, Tauri Group will have to carry out new work and provide non-clinical advisors, process advisors and regulatory affairs managers to support the OPETS programme.
The two contracts enable the company to further strengthen its role in providing solutions to troops.
Tauri Group Asymmetric Threat Mitigation Division director John David said: “We are honoured to be the principal provider of medical specialists to JPEO, and ultimately supporting medical initiatives that impact warfighter safety and mission success.”
The JPEO-CBD is described as the lifecycle manager for chemical, biological, radiological, and nuclear (CBRN) defence products used by the military.
In a statement, JPEO-CBD said: “We sustain the CBRN defence capabilities, which we develop and produce so they are always ready to assist America’s soldiers, sailors, airmen, marines and coast guardsmen in detecting and protecting against CBRN threats, whenever and wherever they occur.”
Founded in 2001, Tauri Group focuses on creating new, multi-dimensional and operationally relevant solutions in order to address national security challenges.